Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

151 results about "Ph gradient" patented technology

Definitions - ph gradient. pH gradient (n.) 1.(MeSH)Energy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work.

Electrochromic display device and compositions useful in making such devices

The present invention relates to a composition and to a display device having the composition positioned between electrodes. The composition contains: (a) a compound that undergoes a reversible redox reaction to generate a pH gradient between the two electrodes, (b) an indicator dye, (c) a charge transport material, and optionally, (d) a matrix material and (e) an opacifier, and (f) secondary redox couple wherein components (a), (b), and (c) are different from one another and the standard reduction potential of component (a) is less than the standard reduction potential for the other components. Depending on the electric field present between the electrodes, a display image may be generated.
Owner:AVESO INC

High drug:lipid formulations of liposomal-antineoplastic agents

A method for encapsulation of antineoplastic agents in liposomes is provided, having preferably a high drug:lipid ratio. Liposomes may be made by a process that loads the drug by an active mechanism using a transmembrane ion gradient, preferably a transmembrane pH gradient. Using this technique, trapping efficiencies approach 100%, and liposomes may be loaded with drug immediately prior to use, eliminating stability problems related to drug retention in the liposomes. Drug:lipid ratios employed are about 3-80 fold higher than for traditional liposome preparations, and the release rate of the drug from the liposomes is reduced. An assay method to determine free antineoplastic agents in a liposome preparation is also disclosed.
Owner:ELAN PHARM INC

Cabazitaxel liposome injection and preparation method thereof

The invention provides a cabazitaxel liposome injection and a preparation method thereof. The cabazitaxel liposome injection comprises cabazitaxel, phosphatide, cholesterol, and mannitol or glucose, and can be prepared through the vacuum film condensation method, the rotary evaporation method, reverse evaporation method, high-pressure homogenization method, and pH gradient method. The cabazitaxel liposome injection has the advantages of reduced toxicity, convenience in clinic, and improved biological availability, and furthermore avoids the a plurality of changes of liposome during the storage process, such as oxidation and hydrolysis of phosphatide, agglomeration and fusion of liposome, and the like, wherein the changes can cause the leakage of coated substance. The invention provides a cabazitaxel liposome which has a good stability and is enough stable in the storage period.
Owner:NANJING LUYE PHARMA

Microorganism electrochemical system capable of realizing electricity generation, hydrogen generation and sewage treatment simultaneously

ActiveCN102340015AIncrease the hydrogen evolution potentialKeep aliveBiochemical fuel cellsEnergy based wastewater treatmentStrong acidsPh gradient
The invention provides a microorganism electrochemical system capable of realizing electricity generation, hydrogen generation and sewage treatment simultaneously, comprising an electrolyzer which is divided into an anode chamber and a cathode chamber by a bipolar membrane, wherein the anode chamber and the cathode chamber are internally provided with an anode and a cathode respectively; the anodes and the cathodes are connected with a resistor by guide lines; each anode is formed by electricity-generating microorganisms and an anode substrate; each cathode is made of an electrochemically inert metal titanium, platinum or carbon material; the anode chamber is internally provided with sewage containing organic pollutants; and the cathode chamber is internally provided with a strong acid solution. In the system, a diaphragm technology is adopted to separate pH gradients of the anode chamber and the cathode chamber; a hydrogen evolution potential of the cathode is improved, and the activity of the organisms in electricity-generating microorganism oxidized sewage of the anode is maintained at the same time; the hydrogen is generated at the cathode at the same time of treating the organisms in the sewage of the anode; and because the cathode potential is improved, and the reaction can be generated spontaneously to output the electricity externally.
Owner:DONGGUAN WOJIESEN WATER TREATMENT

Method and apparatus for improving in vitro measurement of membrane permeability of chemical compounds

This invention improves the PAMPA (parallel artificial membrane permeability assay) method used in pharmaceutical, biotechnological, and agrochemical R&D. This new high-throughput method and apparatus for measurement of permeability and membrane retention of compounds overcomes shortcomings of prior art and includes sensitivity and speed enhancing reagents. The phospholipid membranes used here consist of 10–74% wt / vol soybean lecithin extract dissolved in dodecane. Concentrations are measured by direct UV spectroscopy. To reduce membrane retention, surfactants, cyclodextrins, or water-soluble lipophilic polymers with low UV absorption are used in the acceptor comparment of the permeation cells and create an artificial sink state. A pH gradient established between donor and acceptor solutions creates a secondary sink state. This “double-sink” makes successful modeling of passive-diffusion transport of molecules possible. By accelerating transport of certain molecules, it shortens measurement time and increases assay throughput. A new permeability equation accounts for the “double-sink” condition as well as membrane retention.
Owner:PION

Preparation method of probiotic and aloe mask

InactiveCN105853303ARealize the purpose of skin care and health careCosmetic preparationsToilet preparationsDPPHBacillus acnes
The invention provides a preparation method of a probiotic and aloe mask, which is characterized by preparing a fermentation stock solution from aloe vera raw juice, glucose and water according to certain proportions and adding probiotics for performing co-fermentation. By setting different temperature gradients and pH gradients, after viable count, optimal fermentation conditions are determined; an aloe and probiotic fermentation solution is adopted to carry out an antibacterial test so as to determine an antibacterial effect, such as propionibacterium acnes; and meanwhile, by determining an antioxidant index, the antioxidant ability of the aloe and probiotic fermentation solution is determined, such as determination of DPPH radical scavenging ability, determination of iron ion chelating ability and determination of total reducing force. According to the product, the aloe and probiotic fermentation solution is mixed with cosmetic auxiliary materials in proportion so as to be processed into a pasty mask, and after sensory index testing, skin irritation testing and trial effect testing, the safety and functionality of the product are determined, so that the aims of skin protection and health care are achieved.
Owner:NANCHANG UNIV

In vitro prediction of in vivo half-life

InactiveUS20170227547A1Reducing FcRn-dependent terminal half-lifeChanges the FcRn binding characteristicsSolid sorbent liquid separationImmunoglobulinsRetention timeHalf-life
Herein is reported a method for determining the presence of antibody-Fab-FcRn interaction in an antibody-Fc-FcRn complex influencing the in vivo half-life comprising the steps of a) determining the retention time of the antibody on an FcRn affinity chromatography column with a positive linear pH gradient elution in the presence of a first sodium chloride concentration, and b) determining the retention time of the antibody on an FcRn affinity chromatography column with a positive linear pH gradient elution in the presence of a second sodium chloride concentration, whereby the presence of antibody-Fab-FcRn interaction in an antibody-Fc-FcRn complex influencing the in vivo half-life is determined if the retention time determined in step a) and the retention time determined in step b) are substantially different.
Owner:F HOFFMANN LA ROCHE & CO AG

Off-Gel free flow electrophoresis coupling chip and making method thereof

The invention relates to an Off-Adhesive free flow electrophoresis coupling chip and a making method thereof, belonging to the technical field of microfluidic chip manufacture. The chip comprises a chip substrate, an electrode and a separating chamber, wherein an immobilized pH gradient adhesive tape area and hard substrates for fixing and embedding of immobilized pH gradient adhesive are arranged at the tail end of the separating chamber. The method comprises the following steps: arranging a rectangular area for embedding of the immobilized pH gradient adhesive tape at the tail end of the separating chamber of the other substrate, then aligning the chip substrate with another substrate, carrying out sealing connection on the two substrates and the electrode according to a combined sealing method of the free flow electrophoresis chip to form a free flow electrophoresis chip, arranging the chosen immobilized pH gradient adhesive tape at the rectangular slotting area of the chip, and pressing and fixing the immobilized pH gradient adhesive tape by using the other hard substrate for using. The chip not only solves the defects of the free flow electrophoresis chip and Off-Adhesive electrophoresis technologies, but also inherits the advantages of the two technologies; and the chip has simple manufacturing method, and the immobilized pH gradient adhesive tape is replaceable.
Owner:BEIJING INSTITUTE OF TECHNOLOGYGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products